Board of Directors

  • Karen L. Shoos, J.D.
    Chair; Consultant, AABB International Technical Assistance, Division of Global Services

  • Keith L. Brownlie
    Former Partner, Ernst & Young LLP

  • Herbert J. Conrad
    Former President, Roche Pharmaceuticals US

  • James J. Marino, J.D.
    Former Partner, Dechert LLP

  • Anthony S. Marucci
    Founder, President, Chief Executive Officer and Director

  • Harry H. Penner, Jr., J.D., L.L.M.
    Chairman and CEO, Nascent Bioscience

  • Karen L. Shoos, J.D.
    Chair; Consultant, AABB International Technical Assistance, Division of Global Services

  • Keith L. Brownlie
    Former Partner, Ernst & Young LLP

  • Herbert J. Conrad
    Former President, Roche Pharmaceuticals US

  • James J. Marino, J.D.
    Former Partner, Dechert LLP

  • Anthony S. Marucci
    Founder, President, Chief Executive Officer and Director

  • Harry H. Penner, Jr., J.D., L.L.M.
    Chairman and CEO, Nascent Bioscience

About us

Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response.

 

Our Pipeline